Biotech Discovery Series
November 12, 2025
Baird’s Biotech Discovery Series, which launched in early 2022, is an opportunity for investors to hear directly from interesting and innovative public and private biotech companies in a fireside chat format. Each episode is centered around a key event for the focus company, which can include new clinical data, a material regulatory event, key management additions, a significant new investment, a key acquisition, new entry into the public markets, etc.
Episode Thirty-One: Cellectis, Inc. (CLLS)
Wednesday, November 12, 2025
10:30 A.M. ET (9:30 A.M. CT) ~45 minute duration
Guest Speakers:
- André Choulika, Ph. D., Chief Executive Officer
- Adrian Kilcoyne, MD, MPH, MBA, Chief Medical Officer
Hosted by Mike Perrone, CFA, Healthcare Specialist, Baird
Moderated by Jack Allen, CFA, Baird Senior Research Analyst, Biotechnology
Register here: https://goto.webcasts.com/starthere.jsp?ei=1741315&tp_key=dcd0ddb1f3